UNLABELLED The aim of study was to determine the prevalence of metabolic syndrome (MetS) in people with type 2 diabetes mellitus (T2DM). National Cholesterol Education Program (NCEP) ATPIII Criteria, International Diabetes Federation and the World Health Organization (WHO) definitions were used in quantifying the metabolic syndrome and also the concordance between these three criteria's used fo...

BACKGROUND There has been much debate about changes in the incidence of schizophrenia. AIMS To identify any changes in incidence of schizophrenia in Camberwell, south-east London, between 1965 and 1997. METHOD Research Diagnostic Criteria and DSM-III-R diagnoses were generated for all first contacts by the OPCRIT computer program, and incidence rates of schizophrenia in seven time periods w...

BACKGROUND The 2005 International Diabetes Federation (IDF) definition of the metabolic syndrome was designed to be useful worldwide, but to date few prevalence studies have used that definition in European populations. We estimated the age- and sex-stratified prevalence of IDF-defined metabolic syndrome in a county of Norway and compared it with the prevalence estimated using the revised Natio...

BACKGROUND The prevalence of the metabolic syndrome is rapidly increasing with a considerable ethnic variation within and across populations. This study was conducted to estimate the prevalence of the metabolic syndrome and its individual components using Adult Treatment Panel III (ATP III) criteria among Northern Jordanians. METHODS Data were analyzed from a cross-sectional study that includ...

OBJECTIVE The aim of this study was to identify the prevalence of metabolic syndrome (MetS) and degree of cardiovascular disease (CVD) risk in patients with psoriatic arthritis (PsA). MATERIAL AND METHODS We performed a cross-sectional study on 102 adult patients with PsA and a control group of 102 patients with rheumatoid arthritis (RA). MetS was diagnosed according to the National Cholester...

We determined the prevalence of metabolic syndrome (MS) in Okinawa from cross-sectional results of an annual physical checkup. We also calculated the homeostasis model assessment ratio (HOMA-R) as an index of insulin resistance, and examined the relationship between HOMA-R and MS. We studied 3,839 men (mean age 49.2 years) and 3,146 women (mean age 50.0 years), a total of 6,985 people aged from...

OBJECTIVE To determine the prevalence of metabolic syndrome (MS) in renal transplant recipients (RTR) using the modified Asian National Cholesterol Education Programme-Adult Treatment Panel III (NCEP-ATP III) criteria. METHODS A cross-sectional study was conducted on 200 RTRs between January 2008-August 2008. All were more than six months post transplant and above 18 years of age. Subjects wi...

AIMS This study proposes a computational method for determining the prevalence of metabolic syndrome (MS) and to predict its occurrence using the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria. The Random Forest (RF) method is also applied to identify significant health parameters. MATERIALS AND METHODS We used data from 5,646 adults aged between 18-7...

BACKGROUND The metabolic syndrome (MES) is associated with a high risk of diabetes and cardiovascular disease. The aim of the present study was to determine the prevalence of the metabolic syndrome as well as cut-off points for waist circumference (WC) for diagnosis of MES in Zahedan, southeast Iran. METHODS Totally, 1802 people (735 men and 1067 women) with metabolic syndrome were surveyed a...

BACKGROUND Aglobal obesity epidemic has led to the increased prevalence of non-alcoholic fatty liver disease (NAFLD). NAFLD is now believed to be one of the most common causes of chronic liver disease in the Western world. According the World Health Organization, approximately 300 million people worldwide are obese and this number continues to rise (1). Obesity is related to metabolic condition...